Virax Biolabs | 6-K: Virax Biolabs Group Limited to Participate at ESCMID Global 2024
Apr 16 19:39
Virax Biolabs | 6-K: Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Mar 16 10:33
Virax Biolabs | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 15 04:58
Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)
Jan 22 13:00
Virax Biolabs | 424B5: Prospectus
Jan 22 13:00
Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)
Jan 12 13:00
Virax Biolabs | 6-K: Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in Covid Patients
Dec 21, 2023 20:34
Virax Biolabs | 424B3: Prospectus
Dec 21, 2023 05:12
Virax Biolabs | 6-K: Third Amended and Restated Memorandum of Association
Dec 21, 2023 05:06
Virax Biolabs | 424B3: Prospectus
Dec 21, 2023 05:03
Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 18, 2023 20:37
Virax Biolabs | EFFECT: Others
Dec 18, 2023 13:15
Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 14, 2023 20:43
Virax Biolabs | CORRESP: CORRESP
Dec 13, 2023 13:00
Virax Biolabs | UPLOAD: Others
Dec 12, 2023 13:00
Virax Biolabs | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 8, 2023 19:03
Virax Biolabs | F-3: Registration statement for specified transactions by certain foreign private issuers
Dec 6, 2023 05:06
Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 9, 2023 05:11
Virax Biolabs | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 1, 2023 04:38
Virax Biolabs | D: Filing D
Oct 18, 2023 04:05
No Data
No Data